Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers von van Velzen, Jeroen F, Laros-van Gorkom, Britta A.P, Pop, Gheorghe A.M, van Heerde, Waander L

Volltext

Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study von Willems, Sterre P.E., Simons, Annet, Saes, Joline L., Weiss, Marjan, Rijpma, Sanna, Schoormans, Selene, Meijer, Karina, Cnossen, Marjon H., Schutgens, Roger E.G., van Es, Nick, Nieuwenhuizen, Laurens, den Exter, Paul L., Kruis, Ilmar C., Blijlevens, Nicole M.A., van Heerde, Waander L., Schols, Saskia E.M.

Volltext

The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A von Valke, Lars L.F.G., Verhagen, Marieke J.A., Mulders, Bart T.P.M., Polenewen, Robert, Blijlevens, Nicole M.A., Jansen, Joop H., Mansouritorghabeh, Hassan, Elsheikh, Einas, Reipert, Birgit M., Turecek, Peter L., O'Donnell, James S., Rijpma, Sanna R., Schols, Saskia E.M., van Heerde, Waander L., Meijer, Danielle

Volltext

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases von Valke, Lars L. F. G., Rijpma, Sanna, Meijer, Danielle, Schols, Saskia E. M., van Heerde, Waander L.

Volltext

Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype von Atiq, Ferdows, Boender, Johan, Heerde, Waander L., Tellez Garcia, Juan M., Schoormans, Selene C., Krouwel, Sandy, Cnossen, Marjon H., Laros‐van Gorkom, Britta A. P., Meris, Joke, Fijnvandraat, Karin, Bom, Johanna G., Meijer, Karina, Galen, Karin P. M., Eikenboom, Jeroen, Leebeek, Frank W. G.

Volltext

Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin–deficient patients: Data from the Rare Bleeding disorders in the Netherlands study von Haisma, Bauke, Rijpma, Sanna R., Cnossen, Marjon H., den Exter, Paul L., Kruis, Ilmar C., Meijer, Karina, Nieuwenhuizen, Laurens, van Es, Nick, Schutgens, Roger E.G., Blijlevens, Nicole M.A., van Heerde, Waander L., Schols, Saskia E.M.

Volltext

Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation von van den Eijnde, S M, van den Hoff, M J, Reutelingsperger, C P, van Heerde, W L, Henfling, M E, Vermeij-Keers, C, Schutte, B, Borgers, M, Ramaekers, F C

Volltext

Activity Sensing of Coagulation and Fibrinolytic Proteases von Sondag, Daan, Verhoeven, Stijn, Löwik, Dennis W. P. M., Geffen, Mark, Veer, Cornelis van't, Heerde, Waander L., Boltje, Thomas J., Rutjes, Floris P. J. T.

Volltext

Synthesis and Evaluation of Glycosyl Luciferins von Sondag, Daan, Kleijne, Frank F. J., Castermans, Sam, Chatzakis, Isa, Geffen, Mark, van't Veer, Cornelis, Heerde, Waander L., Boltje, Thomas J., Rutjes, Floris P. J. T.

Volltext

Frontispiece: Activity Sensing of Coagulation and Fibrinolytic Proteases von Sondag, Daan, Verhoeven, Stijn, Löwik, Dennis W. P. M., Geffen, Mark, Veer, Cornelis van't, Heerde, Waander L., Boltje, Thomas J., Rutjes, Floris P. J. T.

Volltext

A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis von Geffen, Mark van, Loof, Arnoud, Lap, Paul, Boezeman, Jan, Laros-van Gorkom, Britta A P, Brons, Paul, Verbruggen, Bert, Kraaij, Marian van, van Heerde, Waander L

Volltext

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A von Eckhardt, Corien L., van Velzen, Alice S., Peters, Marjolein, Astermark, Jan, Brons, Paul P., Castaman, Giancarlo, Cnossen, Marjon H., Dors, Natasja, Escuriola-Ettingshausen, Carmen, Hamulyak, Karly, Hart, Daniel P., Hay, Charles R.M., Haya, Saturnino, van Heerde, Waander L., Hermans, Cedric, Holmström, Margareta, Jimenez-Yuste, Victor, Keenan, Russell D., Klamroth, Robert, Laros-van Gorkom, Britta A.P., Leebeek, Frank W.G., Liesner, Ri, Mäkipernaa, Anne, Male, Christoph, Mauser-Bunschoten, Evelien, Mazzucconi, Maria G., McRae, Simon, Meijer, Karina, Mitchell, Michael, Morfini, Massimo, Nijziel, Marten, Oldenburg, Johannes, Peerlinck, Kathelijne, Petrini, Pia, Platokouki, Helena, Reitter-Pfoertner, Sylvia E., Santagostino, Elena, Schinco, Piercarla, Smiers, Frans J., Siegmund, Berthold, Tagliaferri, Annarita, Yee, Thynn T., Kamphuisen, Pieter Willem, van der Bom, Johanna G., Fijnvandraat, Karin

Volltext

Treatment of patients with rare bleeding disorders in the Netherlands: Real‐life data from the RBiN study von Maas, Dominique P. M. S. M., Saes, Joline L., Blijlevens, Nicole M. A., Cnossen, Marjon H., den Exter, Paul L., Kruis, Ilmar C., Meijer, Karina, Nieuwenhuizen, Laurens, Peters, Marjolein, Schutgens, Roger E. G., Heerde, Waander L., Schols, Saskia E. M.

Volltext

Polymorphisms in the Annexin A5 gene influence circulating Annexin A5 levels in healthy controls von Hiddink, Larissa, de Visser, Marieke C.H, van Heerde, Waander L

Volltext

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation von Valke, Lars L.F.G., Bukkems, Laura H., Barteling, Wideke, Laros‐van Gorkom, Britta A.P., Blijlevens, Nicole M.A., Mathôt, Ron A.A., Heerde, Waander L., Schols, Saskia E.M.

Volltext

Luminescent Assay for the Screening of SARS‐CoV‐2 MPro Inhibitors von Sondag, Daan, Merx, Jona, Rossing, Emiel, Boltje, Thomas J., Löwik, Dennis W. P. M., Nelissen, Frank H. T., Geffen, Mark, 't Veer, Cornelis, Heerde, Waander L., Rutjes, Floris P. J. T.

Volltext

Diagnostic work up of patients with increased bleeding tendency von Zegers, Suzanne A. M., Smit, Yolba, Saes, Joline L., Duren, Clint, Schuijt, Tim J., Heerde, Waander L., Schols, Saskia E. M.

Volltext

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic‐pharmacodynamic model for patients with haemophilia A von Bukkems, Laura H., Valke, Lars L. F. G., Barteling, Wideke, Laros‐van Gorkom, Britta A. P., Blijlevens, Nicole M. A., Cnossen, Marjon H., Heerde, Waander L., Schols, Saskia E. M., Mathôt, Ron A. A.

Volltext

Von Willebrand disease type 2M: Correlation between genotype and phenotype: Reply to comment from Dr. Favaloro and to comment from Dr. Woods et al von Maas, Dominique P. M. S. M., Heerde, Waander L., Schols, Saskia E. M.

Volltext

Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease von Verhagen, Marieke J A, van Balen, Erna C, Blijlevens, Nicole M A, Coppens, Michiel, van Heerde, Waander L, Leebeek, Frank W G, Rijpma, Sanna R, van Vulpen, Lize F D, Gouw, Samantha C, Schols, Saskia E M

Volltext